Developing new prescription medicine for market is a costly and oftentimes, a futile endeavor as drugmakers can spend up to $2.6 billion only to see
FansUnite (FANS.C) is the star of the junior exchanges these past few weeks, accelerating hard on the back of good financial news earlier this month,
Smallcap investors largely see the psychedelics space in one of two ways; you’re either in the ‘this may be big one day but there’s not
Sixth Wave Innovations (SIXW.C), a world leader in molecular detection and extraction, is working to disrupt the market for Covid rapid testing as well as
It’s not all about legal cannabis anymore, Pure Extracts Technologies (PULL.C) CEO, Ben Nikolaevsky, speaks with Equity Guru’s own, Chris Parry, to outline the companies
Yeah, I know, I know. Canadian cannabis companies are ass right now, and have been for a few years. Trust me, I’m about as out
At a time when Hexo Cannabis (HEXO.T) has written off practically everything they’ve ever owned and will rollback 8 to 1 to maintain some chance
Ahead of Kwesst’s initial public offering (IPO), Equity Guru’s own Chris Parry talks with the company’s Executive Chairman David E. Luxton to gives us a
If you’ve ever watched the litany of gold mining programs on cable TV’s reality TV channels, you’ve seen folks jumping up and down like they
Earlier this year, when Revive Therapeutics (RVV.C) announced they had some pharma IP that may be relevant to the treatment of COVID-19, plenty of folks
In the North American biotech space, you hear a lot of ‘promise’ from companies and their teams. Lots of ‘we’re going to take this to
Aequus Pharmaceuticals (AQS.V), a specialty pharma company with a business model of acquiring and re-platforming existing approved biotech and health products to appeal to a
Just a few months since announcing they were merging with Askott Entertainment, a deal that brought casino gaming and daily fantasy sports access to FansUnite’s
Let’s take a step back. Take a breath. Maybe meditate or toss back a tequila shot. Okay, we good for a chat? It’s been a
When we first talked about Tocvan Ventures (TOC.C) back in June, it was selling for around $0.15 and nobody was really talking about it. In
If you’ve been paying attention over the last few years, you’ve seen a few nice runs for companies engaged in the security/military space. Patriot One
For the last several years, a lot of stories I’ve written on this site have been about promise. The promise of something better, cheaper, with
UK-based commodities reporter Pratima Desai appears to have either been a useful idiot or a willing accomplice to a stock price run and subsequent insider
Not so long ago, one of our sales guys called Desert Mountain Energy (DME.V) and said, ‘yo desert bros, we like helium, you got helium,
CEO Peter Berdusco is throwing all the escape plans possible at his Guyana Goldstrike (GYA.V), as the company continues to capsize after three years of
Esteemed California cannabis gummies maker Plus Products (PLUS.C) issued quarterly financials Thursday showing a substantial turnaround as their Nevada and national CBD growth plans take
When folks ask AMPD Ventures (AMPD.C) CEO Anthony Brown what his company does, he usually asks, “Have you seen the Spielberg movie, Ready Player One?”
After a months long quiet period in which investors had to wait patiently for AMPD Ventures (AMPD.C) pipeline contracts to land, a period that also
In the old days, the days when people were allowed to mingle and the threat of pandemic death didn’t loom over us all, making a
E-sports stocks are, by and large, a silly thing right now, with a lot of folks bringing out deals that make little sense financially. As
If you’ve been in the public markets on the microcap side for any length of time, the bodies stack up on your portfolio after a
At a time when some cannabis companies have taken to borrowing money at rates as high as 55%, you’ve got to hand it to any
Formerly dismissed-by-many pharmaceutical company Revive Therapeutics (RVV.C) jumped a whopping 68% Friday upon revealing it has been granted approval to move forward with phase 3
I know you guys are all hopped up on goofballs buying gold right now, and shrooms before that, and biotech if you’re clever, and oil
A few days ago, World Class Extractions (PUMP.C) announced they’d done a deal with a ‘leading licensed producer’ (that we figured out is Aphria –
Look man, when I run my lance of justice through a piece of shit tech company that makes insane promises and almost no money, and
In one of the most unlikely deals we’ve seen in some time, World Class Extractions (PUMP.C) boss Rosy Mondin has announced Cobra Ventures, a 50%
When shareholders gather, it’s rarely for good intentions, and thus we see a pitched battle breaking out at cannabis investment group Australis (AUSA.C) HQ where
If there’s one thing we’ve always said about how we do business at Equity.Guru, it’s that our clients don’t buy our favour, they merely buy
I love it when a plan comes together. Little Falcon Gold (FG.V), that only recently boasted the sort of market cap that would have bought
Talking to Isracann (IPOT.C) COO Matt Chatterton Monday afternoon I asked a question I ask pretty much everyone in the cannabis world right now: Considering
There may well be people at US-based penny stock pump factory Brewbilt Manufacturing (BBRW.OTC) making brewery equipment. We don’t know for sure because they don’t
For a large part of its early days, one of the main selling points of US multi state cannabis store operator iAnthus (IAN.C) was that
I shot out of town for a few weeks recently, managing to get well drenched in a tent in the BC rainforest, and being without
National cannabis retail chain Choom Holdings (CHOO.C) was embarrassed Monday after details of its 27-page appeal to the Vancouver Board of Variance asking that body
CBD-focused CSE companies Sweet Earth (SE.C) and Mota Ventures (MOTA.C) have announced their intent to join forces on the development and distribution of CBD dog
In streaming content news, the recent Microsoft experiment of trying to compete with Amazon-owned Twitch with their own Mixer platform, has come to a sorry
This week’s digest of mushroom moves is a mixed bag of trash and glory, with the shrooms sector increasingly looking like the early days of the cannabis rush.
Loblaws’ (L.T) big ass 1300-store pharmacy chain, Shoppers Drug Mart, announced this morning they’re now offering same day delivery of medical cannabis products in the
The Greater Fool Theory is the single greatest driving force of the markets right now. Balance sheets can eat a dick. Growth potential is irrelevant.
When we first heard of Vodis Pharma (VP.C) it was a tiny group that couldn’t get its unlicensed Delta BC-based cannabis facility looked at by
When a company shows up out of nowhere and announces they’re buying a newspaper, but that nothing will change if not for the better, that they have money and resources to compliment what’s already there, and that journalism will always be at the core of what they do, don’t buy it. It’s always a lie. In March, Media Central (FLYY.C) CEO Brian Kalish got in front of a camera to talk about how, ‘hey guys, we know the Georgia Straight has been around for 53 years, but we’re bringing it back to its heart.’
Ever get the feeling, looking at your watchlist, that you’re seeing the same thing over and over? That maybe there’s interesting stuff out there you just haven’t heard about yet? I put a simple question to Twitter today: “Give me a ticker symbol you think I should be writing about (limit one per person), three reasons you think it’s great, and one thing you’ll openly admit they need to do better.” I got 35. Gulp.
I love it when a plan comes together. Predictmedix (PMED.C) continued to launch itself upward this week, jumping from $0.72 to $0.98 in just days,
Far be it for me to stand up for Canopy Growth Corp (WEED.T), a company that has only succeeded in one thing in its entire existence; convincing folks to buy its stock despite never having done anything else right. In recent quarters, and through three CEOs, Canopy has been pretty darn forthright that it was going to lose money for a while because it was broken.
Because this story is about The Green Organic Dutchman (TGOD.T) and cannabis investors bear grudges, the vast majority of people reading it will already be saying the words, “Fuck Parry, you’ll pump anything for money.”
So let’s get some things out of the way before we start. 1) TGOD isn’t paying for this story, and haven’t been a client for well over a year. 2) TGOD might not be a fan of this story
When weed legalized in Canada, I wasn’t a consumer participant. Smoking up has never been my jam. I know some like the ritual of it
When the history books are written on this passage of our lives, under pandemic lockdown and with once-in-three-generations levels of unemployment, they’ll note that in
Micro-mobility ride-sharing, which is the terminology that’s been coined for e-scooters, bike-shares, mopeds and the like, is clearly an idea that has a future. Small enough to park anywhere (we’ll get to the dark side of that in a second), cheap enough to mass produce, able to be electrified and charged easily, and tied to a payment app that tracks a load of data, this business concept has everything going for it – and is being fucked up by just about everyone involved.
If Tilray (TLRY.Q) will leave any sort of legacy on the Canadian cannabis landscape, it will be that, for a short time and by virtue of a well-timed and paper-lined public listing, the CEO was the highest paid CEO in North America. For a hot minute, Americans bought in by the truckload and drove the shareprice up like DryShips (DRYS), making the boss a very paper rich man. Everything else the company has managed to achieve has been downhill from there.
We get a lot of clients wanting to be written about on Mondays because that’s when everyone drops their good news. I usually try to
I break laws sometimes. I speed on the highway. I possess more than the 30 gram legal limit of weed products. I sneak food into
For a company that once upon a time figured a great business model in the cannabis sector would be to tattle on other license holders
Supreme Cannabis (FIRE.T) got a new President and CEO today in Beena Goldenberg, former chief executive officer of Hain-Celestial Canada, and a bona fide pro in the natural and plant-based consumer packaged goods business. This would appear to be a good hire for a company that already has a great reputation for quality products in an industry where the only way to differentiate yourself is being absurdly cheap or absurdly good. She’s picked a fine time to jump in; the company has already done some hard work in turning its fortunes around, and (to me) looks like its found a nice bottom to launch off.
At Equity.Guru, we’ve been tight with Nexus Gold (NXS.V) boss Alex Klenman for years. he’s been through it with Nexus, from former CEOs selling off his stock in secret, filing their insde trading docs a year late, to stock promoters demanding money and then, upon being refused, crashing the stock, to dark pool shenanigans and more. We’ve laid out a lot of those issues in the past as an explanation how a gold explorer that seems to have some interesting land packages, and does regular work, can find itself so damnedly underwater for so long. Company puts out news, stock starts to lift, massive selling bangs it down. Company puts out news, massive sell orders show up that spook the market, stock drops, sell orders go away.
“Let them say what they want, we know what we’re doing, and we’re doing the work,” Michael Frank told me a month ago, as he
Karim Rayani is a deal guy from way back, a non-stop money raiser, deal maker, handshaker and groover/shaker. If you needed a guy to invest in a biotech deal, Karim would go find him. If you needed some dough to kickstart a palladium mine, Karim will have a guy who knows a guy. And if you needed someone to write about your company, he’d be on the phone bothering me several times a day, squeezing me on my rate, selling me a tale that these guys. “My man, these guys, you have to meet them, they have something special. Sometimes it would even be special.
There’s no doubt a lot of people invest in a sector by just plopping their dough behind whichever company is the biggest, or the one
The Wayland Group (WAYL.C) announced Thursday Austria-based Ring Holding International AG will purchase their Maricann assets, which essentially make up their entire business, for the bargain price of $12.3 million as part of ongoing bankruptcy proceedings. The purchaser of the Maricann assets is a family office with a core focus on the manufacturing of lever arches used in ring binders. Yes, ring binders.
Oddball pharmaceutical player Revive Therapeutics (RVV.C) found itself on the back end of a warning by the BCSC this week, that certain German players in the smallcap promotion space had over-hyped the mushroom/cannabis/biotech deal and promised big wins inappropriately for anyone who invested. As a marketing partner of Revive, I got a few panicky texts from certain folks wondering if that meant trouble for us – or them. It’s not a problem for us; our coverage has been appropriately even-handed.
When the cannabis edibles space first became a potentially legal thing in Canada, my first thought was about how my life would change for the
Long time readers know, a year or two back, we wrote a lot about a US multi-state operator (MSO) in the cannabis dispensary space, iAnthus (IAN.C). We liked the company as it accelerated its dispensary acquisition program but stopped coverage in early 2019, with the shareprice in the $5 range, as it began to overpay for assets in a land grab with competitors we believed would ultimately have few winners. Today, iAnthus has put out some uncomfortable news announcing that, because it is involved in a lawsuit with creditors, it has chosen to default on debenture interest payments.
I have a list of companies that want me to write about them that, for the last few years, has never got to an end.
It’s never been clearer that many Canadian cannabis companies were built, from the outset, poorly. As the economy creaks and groans and every sector takes
Trust me, there’s nothing I’d like more, as the publisher of a financial markets-focused media outlet, than to tell you all it’s time to buy
When new sectors emerge, as cannabis did in 2013 and psychedelics are doing right now, microcap companies that have struggled in other sectors will often pivot into new business. Miners become weed companies, then biotech companies, then shroom companies, as boards and management pursue new opportunities that might one day prove better than the last.
GTEC Holdings (GTEC.C) is a company we’ve written about a lot, a BC-based cannabis grower that laid out a business model of multiple small licensed grow facilities, hitting the premium artisan weed market. Their products are great, their costs are low, and they’ve never yet benefited from the irrational weed booms of the ’15, ’16, and ’17 years because they were late to get those licenses.
This means, they’ve experienced all the weed industry dives, but none of the runs. Their stock price: $0.09, good for a market cap of just $11 million.
When the savings and loan crisis in the US hit in 1989, a lot of slow-moving investors lost their dough thinking the worst couldn’t possible
No company in the Canadian cannabis space polarizes people like Green Organic Dutchman (TGOD.T), which roared to the public markets on perhaps the biggest promote yet seen, raised nine-digit totals along the way, swept in more first time private placement participants than any company before them, and then did… well… nothing, for a long time. With top brass having been walked recently and plans to super-size the company grow facilities shelved in the wake of underwhelming need for more weed, TGOD has made no secret it is at a moment of recalibration, but investors will have expected to see more than this.
Okay, so the world is burning, the Russians and Saudis are pouring low-cost fuel over it, the Americans are shocked that a reality TV show
Today was a day that daytraders have been looking forward to for some time; the day that shroom stocks finally gripped the road and took off. Mind Medicine (MMED.E) ripped 90% to $0.77 on the back of 15m shares traded, reminding anyone who’d listen that ex-Canopy CEO Bruce Linton and pretend billionaire Kevin O’Leary were on board. Champignon Brands (SHRM.C) zoomed 40% to $0.33 on a lot smaller market awareness spend byt a handy ticker, Roadman Investments (LITT.V) was up 30% to $0.065 being sucked along in the other two companies’ wake, and Revive Therapeutics (RVV.C) was up 81% to $0.10 on ripples caused by the rest.
A quick scan of headlines today would tell a harrowing story that Heritage Cannabis (CANN.C) was in big trouble and had lost $13 million and pandemonium had broken loose, and dogs and cats were going to be living together any time now. That’s because the company led their Q4 financials news release today with their yearly metrics filling the headlines, while their not-so-rough quarterly numbers were largely and inexplicably hidden from view.
As happens whenever a global crisis hits, there are plenty of investors currently watching the global Coronavirus outbreak and looking to panic sell. There are also a few looking to capitalize on the opportunities found in potential doom. Like folks who buy gun stocks whenever a military conflict breaks out, or those who buy gold as a safe haven when the world’s leaders engage in a game of ‘Armageddon chicken.’ a pandemic brings about macroeconomic changes that can be utilised to make money.
Invictus MD Strategies (GENE.V) announced tonight that, in accordance with its efforts to work through creditor protection proceedings, it has been kicked off the Venture Exchange. On the upside, if Invictus’ history of going back on news releases is anything to go by, we’ll receive another release inside ten days that the bankruptcy proceedings have been cancelled and they’ll continue on as usual. Because that’s how it’s always been for Invictus, which has the worst track record in Canada’s cannabis space for announcing things, only to un-announce them very shortly after.
Respect where it’s due, I haven’t been to an investor conference in a long time where I came away interested in most of what I saw, let alone *everything* I saw, but this year’s Gravitas Securities Growth Conference lineup absolutely hit it out of the park. The GSGC isn’t the biggest show around, but they know how to turn out the playahs, and the only way you keep big money showing up is to be a little bit picky with what you offer them. Don’t waste anyone’s time and they’ll know it’s cool to return.
As part of an ongoing process to deal with its bankruptcy, Wayland Group (WAYL.C) is dispensing with several foreign assets that were once touted as being amazing international opportunities, and it’s doing so at prices you can afford. The courts have granted approval for WAYL to get rid of its Colombian subsidiary, Colmed Pharmaceuticals, which was purchased in an all paper deal for 11 million shares a little over a year ago. Who’s buying it? It turns out, one of the companies that originally sold it to them, RG5 Investments.
With a little over and hour left in the year 2019, past 10PM on December 31, I saw a news release from James E. Wagner Cultivation (JWCA.V) about a small $2 million loan they’d taken out. The timing of the announcement of their loan was surely not coincidental. Actually, thinking about it, ‘payday loan’ might be the more appropriate term to have used. JVCA took out a debenture financing of $2 million at an interest rate of 25% annually. That’s just the first tranche of the deal; there’s another $8 million out there if they want it. My credit card, abused as it has been, costs me less interest to maintain than JWCA’s loan.
You’ve gotta love it when a plan comes together: 1933 Industries (TGIF.C), which has been banging the same ‘we’re grownups, we’re doing it right, hang tight’ drum for several years now, dropped news this February 14 that will make any Valentine’s heart swell with joy. “Following the completion of a combined 20,000-square-foot expanded cultivation, extraction, manufacturing and distribution facility in the Los Angeles area, the company began harvesting its first cannabis crop this week to be utilized for both its proprietary brand Alternative Medicine Association (AMA), as well as for its licensing partner luxury brand Blonde cannabis, with products earmarked for dispensaries for the first time outside of Nevada.”
Ontario-based Supreme Cannabis (FIRE.T) released its Q2 2020 financials today and there were few surprises contained in its pages, bar perhaps the size of the quarterly loss. At a $17.3 million net loss after taxes (and a $10.4 million loss in adjusted EBITDA terms), FIRE shares fell in value below the $0.40 mark it’s been hovering around for some time, a 5% drop in real terms. Previous quarters had seen smaller losses, even come close to break even. But even the rosiest-eyed fanboy would have expected these numbers to be rough, considering the CEO change and staff layoffs announced earlier in the year. We predicted as much a week ago.
The quarterly financials news release just put out by Aurora Cannabis (ACB.T) isn’t exactly hype. It reflects a company coming to grips with the fact
Large Canadian cannabis licensed producer Supreme Cannabis (FIRE.T) told the markets they’re laying off around 30% of their staff today, days before their next quarterly financials are released and with the dust still settling after their recent CEO change. To the casual observer, this might appear to be a sign of desperation, that the sky is falling in Kincardine, Ontario, and the owner of the esteemed 7 Acres brand was making some sort of last ditch effort to stave off Armageddon. It ain’t that.
AMPD Ventures (AMPD.C), which recently topped up its bank account to bring in more sales folks, announced some sales today, with a news release pointing
Alberta-based Aurora Cannabis (ACB.T) took a long trade halt today as it prepared to announce what the online rumour mill had been surmising all day
If you’ve had your eye off the biotech sector recently because it doesn’t directly involve gold or cannabis, you’re missing out on one of the
BC-based battery metals developer Nano One Materials (NNO.V) has long been a favourite at Equity.Guru – in fact, it’s been the stock we’ve held longest
If you guys can’t spot a bubble by now, what day in February did you start trading exactly? Tesla (TSLA.Q) stock has been on a nutty run lately, climbing from the $200 range in October to $969 yesterday. Or, rather ‘..to $969, 15 minutes before the end of trading today.’
A year ago, if you’d told me a rare earths explorer was going to be a three-bagger through tax loss season, I’d have called you
Xphyto (XPHY.C) is dominating the cannabis sector like Sean Kemp used to dominate the Seattle buffet scene. It’s a legit beast right now, jumping from
The giant sports entertainment promoter and one-time pro-wrestling monopoly, World Wrestling Entertainment (WWE.NYSE), hit hard times this past week, as senior management positions unexpectedly opened
Three months ago, I wrote about a drone company called Draganfly (DFLY.C), which had just landed on the exchange as a newly listed public company.
You hate to see it, but such is life in the mining game; little Hawkeye Gold and Diamond (HAWK.V), which may be a misnomer because
From the day it landed on the stock market, MedMen (MMEN.C) was a company that drew derision and ire based almost entirely on the decision
It never ceases to amaze me how folks prefer to get their trade order in before doing their research, even on companies dripping in debt,
All the signs were there: A long awaited move to production, a long period of silence broken with news, a financing near the 52-week low
I love it when a plan comes together. I especially love it when so-called ‘analysts’ who move furniture for a living and buy stock in
